Company news
Zhejiang Gongdong Medical Technology Co. Ltd. Class A (SSE:605369) news
Zhejiang Gongdong Medical Technology Co. Ltd. Class A news releases on 6ix. Latest, Sep 2, 2026: "Zhejiang Gongdong Medical Technology Co., Ltd."Announcement…
View Zhejiang Gongdong Medical Technology Co. Ltd. Class A →
Press releases & updates
"Zhejiang Gongdong Medical Technology Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 1, 2026
"Zhejiang Gongdong Medical Technology Co., Ltd."Semi-annual Report for 2026
August 24, 2026
"Zhejiang Gongdong Medical Technology Co., Ltd."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business License
August 18, 2026
"Zhejiang Gongdong Medical Technology Co., Ltd."Announcement on Receipt of U.S. Tariff Refund by Wholly-owned Subsidiary
August 12, 2026
"Zhejiang Gongdong Medical Technology Co., Ltd."Announcement on Implementation of Repurchase and Cancellation of Certain Shares under the Phase I Employee Stock Ownership Plan
July 30, 2026
Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025
June 29, 2026
Announcement on Abnormal Fluctuations in Stock Trading
June 25, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 11, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 21, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 12, 2026
Announcement on Change of Chief Financial Officer
April 27, 2026
Announcement on Renewing Engagement of Accounting Firm
April 23, 2026
ZHEJIANG GONGDONG MEDICAL TECHNOLOGY CO., LTD. Announcement on Obtaining CNAS (China National Accreditation Service for Conformity Assessment) Laboratory Accreditation Certificate
February 2, 2026
Announcement on Change of the Signing Accountant
January 26, 2026
Earnings Preannouncement for 2025
January 23, 2026
Announcement on "Corporate Value and Return Enhancement" Action Plan
December 22, 2025
Announcement on the Result of Shareholding Reduction by Shareholder and Equity Change Reaching the 1% Scale
December 16, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
October 31, 2025
Report for Q3 2025
October 29, 2025
Announcement on Completing the Filing of the "Articles of Association"
October 9, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 24, 2025
Announcement on Resolutions of the 17th Meeting of the 3rd Board of Directors
September 18, 2025
Announcement on Shareholding Reduction Plan for Shareholders
September 4, 2025
Announcement on Resolutions of the 16th Meeting of the 3rd Board of Directors
August 25, 2025
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
July 24, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 19, 2025
Announcement on Early Termination of Share Reduction Plan and Result of Shareholding Reduction by Shareholders with Over 5% Shares, Directors and General Manager
May 30, 2025
Announcement on Resolutions of 2024 Annual General Meeting
May 27, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 8, 2025
Report for Q1 2025
April 25, 2025
Announcement on Changing Registered Capital and Amending the Articles of Association
April 21, 2025
Announcement on Completion of Non-trading Transfer under Phase I Employee Stock Ownership Plan
April 3, 2025
Indicative Announcement on Changes in Shareholder's Equity
March 18, 2025
Announcement on Resolutions of the 1st Holders' Meeting for the Phase I Employee Stock Ownership Plan
March 13, 2025
Announcement on Appointment of Deputy General Manager
February 20, 2025
Announcement on Share Reduction Plan of Over 5% Shareholders, Directors, and General Manager through Call Auction
February 16, 2025
Announcement on Expected Increase in Annual Performance for 2024
January 22, 2025
Announcement on External Investment
January 10, 2025
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
December 27, 2024
Announcement on Resolution of the 11th Meeting of the 3rd Board of Directors
December 11, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
November 21, 2024
Announcement on Completing Renewal of Medical Device Production License
November 13, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 11, 2024
Notice on Convening the 2nd Extraordinary General Meeting in 2024
November 5, 2024
Report for Q3 2024
October 29, 2024
Announcement on Implementation of Semi-annual Dividend Distribution in 2024
October 15, 2024
Announcement on Resignation of Director and Senior Management Member
September 26, 2024
Announcement on Implementation Results of Repurchasing Shares and Share Changes
September 20, 2024
Announcement on the Progress of Share Repurchase
September 2, 2024
Announcement on Semi-annual Profit Distribution Plan 2024
August 26, 2024